Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR) rose 15.6% during trading on Friday . The stock traded as high as C$16.82 and last traded at C$16.67. Approximately 106,840 shares were traded during trading, an increase of 292% from the average daily volume of 27,226 shares. The stock had previously closed at C$14.42.
Cipher Pharmaceuticals Price Performance
The business’s fifty day moving average price is C$14.90 and its 200 day moving average price is C$14.94. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.12 and a quick ratio of 2.67. The stock has a market cap of C$428.75 million, a P/E ratio of 25.22 and a beta of 1.33.
Cipher Pharmaceuticals Company Profile
Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.
Read More
- Five stocks we like better than Cipher Pharmaceuticals
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- A personal warning from Martin Weiss (Please read)
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
